Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04606173 · ClinicalTrials.gov registry record · NA
Adjunctive Team Enhanced Intervention to Improve Suicide Prevention Evidence-Based Practices in Primary Care
A NA study of Suicide Prevention, sponsored by Syracuse VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT04606173: Completed NA study of Suicide Prevention, sponsored by Syracuse VA Medical Center.
NCT04606173 is a NA study of Suicide Prevention that has completed, run by Syracuse VA Medical Center. The registered enrollment target is 27 participants, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04606173, a NA study of Suicide Prevention, has completed, sponsored by Syracuse VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to evaluate the feasibility and acceptability of a brief educational intervention (TEACH) that includes evidence-based strategies designed to improve task-specific teamwork and its impact (vs. standard practice) on teamwork among primary care team members and on evidence-based suicide prevention care provided to Veterans in Primary Care.
Primary Outcome
4-item Likert-scaled self-reported questionnaire, Expectancy Rating Scale (ERS) assessing the primary care team's perceived feasibility of TEACH. The total score ranges from 0 to 40 with higher scores indicating higher feasibility.
Conditions Studied
Interventions
- OTHER Team Education for Adopting Changes in Healthcare (TEACH)
Study Locations (1)
New York
- Syracuse VA Medical Center - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-06-24 |
| Est. Completion | 2023-04-17 |
| Phase | NA |
What the finished NCT04606173 record still lists
NCT04606173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 1 intervention - of which Team Education for Adopting Changes in Healthcare (TEACH) is the first listed.
NCT04606173 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04606173 about?
NCT04606173 is a clinical study titled "Adjunctive Team Enhanced Intervention to Improve Suicide Prevention Evidence-Based Practices in Primary Care". The purpose of the proposed study is to evaluate the feasibility and acceptability of a brief educational intervention (TEACH) that includes evidence-based strategies designed to improve task-specific teamwork and its impact (vs. standard practice) on teamwork among primary care team members and on ...
What is the current status of trial NCT04606173?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-06-24. Estimated completion is 2023-04-17.
What conditions does trial NCT04606173 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT04606173?
The interventions under investigation include: Team Education for Adopting Changes in Healthcare (TEACH) (OTHER).
Who is sponsoring clinical trial NCT04606173?
This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04606173 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04606173's enrollment target sits among peer trials
27 22nd of 21 the lowest of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Efficacy-Implementation Study for PC CARES in Rural Alaska
RECRUITING · NA
-
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI